DX Innovation Day: Clinical Symposium
We pioneer breakthroughs in healthcare. For everyone. Everywhere.
DX Innovation Day: Clinical Symposium
During this one-day virtual symposium, we will address the new trends and current concepts in diseases that are becoming more prevalent in the liver, kidney, and heart. The event will provide a platform for clinical experts to share their best practices and limitations in real-life situations.
Attendees will benefit from the following:
- How to improve assessment of non-alcoholic fatty liver disease with non-invasive testing options
- How to monitor residual renal function accurately with one single serum test
- How to drive cardiac testing forward with high-sensitivity troponin I
26 July 2022, Tuesday
10.00 am - 4.30 pm Malaysia time
Virtual
Agenda
Screening and Management of NAFLD: The Value of the ELF Test
Speaker: Professor Elizabeth Powell, Hepatologist, Princess Alexandra Hospital
Intelligent Liver Function Testing: Automated Diagnosis and Staging of Liver Disease
Speaker: Dr Pearline Teo, Clinical Consultant, Laboratory Diagnostics, Siemens Healthineers
Utility of Beta-Trace protein in the Management of Renal Dialysis Patients
Laboratory Medicine’s Role in Appropriate Clinical Utilization of High-Sensitivity Cardiac Troponin Assays
Transitioning to High- Sensitivity Trop I: Experience Sharing from UMMC
Speaker: Dr Farhi Ain Binti Jamaluddin, Chemical Pathologist, University Malaya Medical Centre
High-Sensitivity Troponin Assays in Clinical Perspective: The Emergency Medicine Perspective
Speaker: Professor Louise Cullen, Emergency Physician, Royal Brisbane and Women’s Hospital
Heart Matters: Innovations to drive cardiac testing forward
Speaker: Dr Pearline Teo, Clinical Consultant, Laboratory Diagnostics, Siemens Healthineers